Woodline Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Woodline Partners's WST Position: Q3 2026 in Review
Woodline Partners increased its West Pharmaceutical (WST) stake by 4.7% in Q3 2026, buying an estimated $257K and bringing the position to 16,226 shares worth $6.02M. The position accounts for 0.02% of the portfolio, ranked #668.
Woodline Partners first reported a position in WST in Q4 2020 and has held it in 12 quarters since. The position peaked at $66.2M in Q3 2025. 878 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Woodline Partners held 16,226 shares of West Pharmaceutical worth $6.02M as of Q3 2026.
- Woodline Partners bought 728 West Pharmaceutical shares in Q3 2026, an estimated $257K.
- West Pharmaceutical made up 0.02% of Woodline Partners's portfolio in Q3 2026, its #668 holding.
- Woodline Partners first reported a position in West Pharmaceutical in Q4 2020 and has held it in 12 quarters since.
- Woodline Partners's West Pharmaceutical position peaked at $66.2M in Q3 2025.
- 878 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Woodline Partners's 13F filing for Q3 2026, filed 16 Nov 2026.